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Summary
Hypertension affects more than 1.5 billion people worldwide but the precise cause of elevated
blood pressure (BP) cannot be determined in most affected individuals. Nonetheless, blockade of
the renin-angiotensin system (RAS) lowers BP in the majority of patients with hypertension.
Despite its apparent role in hypertension pathogenesis, the key cellular targets of the RAS that
control BP have not been clearly identified. Here we demonstrate that RAS actions in the
epithelium of the proximal tubule have a critical and non-redundant role in determining the level
of BP. Abrogation of AT1 angiotensin receptor signaling in the proximal tubule alone is sufficient
to lower BP, despite intact vascular responses. Elimination of this pathway reduces proximal fluid
reabsorption and alters expression of key sodium transporters, modifying pressure-natriuresis and
providing substantial protection against hypertension. Thus, effectively targeting epithelial
functions of the proximal tubule of the kidney should be a useful therapeutic strategy in
hypertension.
Introduction
Among the regulatory systems for blood pressure (BP), the RAS has a dominant role (Le et
al., 2008). Pathological activation of the RAS is a common contributor to hypertension in
humans as RAS antagonists lower BP in the majority of patients with essential hypertension
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(Matchar et al., 2008). The actions of the RAS to increase BP are primarily mediated by
activation of type 1 (AT1) angiotensin receptors. AT1 receptors are expressed in a number of
tissues where they have a potential to affect BP including the CNS, heart, vasculature,
kidney, and adrenal gland (Le et al., 2008), but it has been difficult to identify the critical
tissue targets of the RAS in hypertension pathogenesis.
Recent studies have implicated vascular signaling pathways as key contributors to BP
regulation and development of hypertension (Guilluy et al. 2010; Heximer et al., 2003;
Michael et al., 2008; Wirth et al., 2008). On the other hand, the work of Guyton and
colleagues (Guyton, 1991), human genetic studies by the Lifton laboratory (Lifton et al.,
2001), and our recent studies in mice (Coffman and Crowley, 2008) have suggested that
renal excretory function is a major determinant of intra-arterial pressure. In the kidney, AT1
receptors are expressed in epithelial cells along the nephron (Bouby et al., 1997). Among
populations of renal epithelia, AT1 receptors in the proximal tubule may have special
relevance to BP homeostasis since: this segment is responsible for reabsorption of a sizeable
fraction of the glomerular filtrate (Weinstein, 2008), it contains all of the components of the
RAS under independent local control (Kobori et al., 2007; Navar et al., 2002), and RAS
activation is known to influence its handling of solutes and fluid (Cogan, 1990).
Nonetheless, while direct actions of angiotensin II in the proximal tubule were first
identified more than 25 years ago (Schuster et al., 1984), their impact on regulation of BP in
the intact animal has never been clearly defined. Here we demonstrate potent actions of AT1
receptors in renal proximal tubule to regulate BP homeostasis.
Results
Reduced BP in mice lacking AT1A receptors in the renal proximal tubule
We crossed mice with a conditional Agtr1a allele (Figure S1) with a Pepck-Cre transgenic
mouse line expressing Cre in proximal but not distal nephron segments (Rankin et al., 2006)
(Figure S2A, B) to generate mice lacking AT1A receptors only in the renal proximal tubule
(PTKO). As shown in Figure 1A, systolic BPs, measured by radiotelemetry were
significantly lower in PTKOs (126±3 mm Hg) than littermate controls (136±3 mm Hg;
p=0.03). This difference was apparent both during the day (120±3 vs. 130±3 mm Hg;
p=0.003) and at night (133±3 vs. 142±3 mm Hg; p=0.04). Mice were then sequentially fed
high (6% NaCl) and low (<0.002% NaCl) salt diets while their BPs were monitored. As
shown in Figure 1B, BPs increased significantly and to a similar extent in both groups
during high salt feeding and returned to baseline levels when the low salt diet was instituted,
consistent with the phenotype of sodium-sensitivity previously reported in 129 mice
(Francois et al., 2005); the magnitude of BP difference between the PTKOs and controls
remained constant across the different dietary sodium intakes.
To exclude the possibility that vascular responses mediated by AT1 receptors might be
affected in the PTKOs, we assessed acute pressor responses to angiotensin II in vivo as
described previously (Ito et al., 1995). As shown in Figure 1C, acute infusion of angiotensin
II caused marked vasoconstriction and the magnitude of the vasoconstrictor responses was
virtually identical in both groups.
AT1A receptors in the proximal tubule control fluid reabsorption
To determine whether deletion of AT1A receptors would affect fluid handling in the
proximal tubule, we examined nephron function using free-flow micropuncture (Hashimoto
et al., 2005). As shown in Table 1 and Figure 1D, absolute rates of proximal fluid
reabsorption (4.76±0.32 vs. 7.5±0.58 nl/min; p=0.00014) were significantly reduced in the
PTKOs compared to controls. Single nephron GFRs measured in the proximal tubule were
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also significantly lower in the PTKOs (13 ± 0.61 nl/min) than controls (16.54 ± 0.81 nl/min;
p=0.001), consistent with the whole animal values (Table 1). Nonetheless, when corrected
for SNGFR, fractional reabsorption rates in proximal tubule were also significantly lower in
the PTKOs (36.5±1.5%) than controls (44.5±1.6 %; p=0.0005, Figure 1E). Thus, loss of
AT1A receptors from the proximal tubule leads to a reduction in fluid reabsorption,
indicating a tonic role for the RAS to control fluid reabsorption by proximal tubule epithelia
in vivo.
PTKO mice are protected against hypertension
To determine the contribution of AT1A receptors in the proximal tubule to the development
of hypertension, we infused PTKO and controls mice with angiotensin II (1000 ng/kg/min)
by osmotic mini-pump. As shown in Figure 2A, the control group developed robust
hypertension with a mean systolic BP of 172±4 mm Hg, which was significantly higher than
that of the PTKOs (150±4 mm Hg; p=0.0005). A similar difference was observed comparing
the mean increase in BPs in the controls (38±5 mm Hg) with the PTKOs (23±3 mm Hg;
p=0.0005) (Figure 2B). Thus, deletion of AT1A receptors from the proximal tubule
conveyed substantial protection against hypertension. As shown in Figure 2C, the extent of
positive sodium balance was significantly reduced in PTKOs (0.33±0.04 mmol) compared to
controls (0.50±0.07 mmol; p=0.046), consistent with facilitated natriuresis as a mechanism
for their resistance to hypertension.
Control of renal sodium transporters by AT1A receptors in proximal tubule
To examine the molecular mechanisms responsible for the attenuated hypertension and
enhanced pressure natriuresis in PTKOs, we measured abundance of key sodium
transporters along the nephron (Figure 3). At baseline, there were no differences in
abundance of any of these transporters between PTKOs and controls. However, during
angiotensin II infusion, significant differences in pool sizes of key transporters were
uncovered. In control mice, abundance of the sodium-proton antiporter 3 (NHE3), the major
sodium transporter in the proximal tubule, fell by ≈30% during angiotensin II infusion
(Figure 3A and B). By contrast, in the PTKOs, abundance of NHE3 fell by more than 50%
(Figures 3A and B) to levels that were significantly lower than controls (0.50±0.06 vs.
0.70±0.09; p=0.01). In control mice, levels of the sodium phosphate co-transporter (NaPi2),
were unaffected by angiotensin II infusion (Figure 3C and D), whereas NaPi2 protein levels
decreased by ≈36% in the PTKOs (p=0.005).
Abundances of the sodium-potassium-two-chloride co-transporter (NKCC2), a major
sodium transporter downstream in the thick ascending limb of the loop of Henle, were
equivalent at baseline in the two experimental groups (Figure 3), and fell to a similar extent
during angiotensin II infusion (Figure 3E and F). Similarly, total protein abundance of the β
subunit epithelial sodium channel (ENaCβ), expressed from late distal nephron through
collecting ducts, and the α1 subunit of the sodium-potassium ATPase (Na,K-ATPase),
expressed all along the nephron, were unaffected in PTKO mice (Figure S3A, B).
Discussion
The importance of AT1 angiotensin receptors in clinical medicine is highlighted by the
impressive cardiovascular benefits of angiotensin receptor blockers (ARBs). As anti-
hypertensive agents, these drugs are effective and well tolerated (Matchar et al., 2008),
ameliorating morbidity and mortality associated with cardiovascular diseases (Pfeffer et al.,
2003) (Brenner et al., 2001; Lewis et al., 2001; Yusuf et al., 2008). By inference, these
clinical studies indicate powerful contributions of AT1 receptors to the pathogenesis of
cardiovascular disease, hypertension, and kidney damage. However, the specific cellular
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targets responsible for their pathological actions cannot be identified from studies using
pharmacological inhibitors that block AT1 receptors in all tissues.
The kidney has been suggested play a predominant role in BP control. Guyton hypothesized
that the substantial capacity of the kidney to excrete sodium provides a compensatory
system of virtually infinite gain to oppose processes, including increases in peripheral
vascular resistance, which would tend to increase BP (Guyton, 1991). This hypothesis is
supported by the genetic studies of Lifton and associates linking Mendelian disorders
impacting BP homeostasis to genetic variants affecting salt and water handling by the
kidney (Lifton et al., 2001). On the other hand, a series of recent studies have suggested that
vascular dysfunction alone may be sufficient to cause hypertension (Guilluy et al.; Heximer
et al., 2003; Michael et al., 2008; Wirth et al., 2008). For example, studies by Guilluy and
associates indicate that elimination of Arhgef1, a Rho exchange factor linked to AT1
receptor signaling, from smooth muscle apparently results in a complete abrogation of
hypertension (Guilluy et al., 2010).
In previous studies using renal cross-transplantation, we found distinct and significant roles
for AT1A receptor actions in both the kidney and extra-renal tissues to BP homeostasis
(Crowley et al., 2005). In hypertension, however, receptors inside the kidney played the
dominant role, driving elevations in BP as well as the development of cardiac hypertrophy
(Crowley et al., 2006). This was due to direct actions of AT1 receptors in the renal
parenchyma, independent of aldosterone. Within the kidney, AT1 receptors are widely
expressed in vasculature, in glomeruli, and by populations of epithelial cells across the
nephron (Bouby et al., 1997). Activation of AT1 receptors at any or all of these sites could
potentially impact BP regulation.
Actions of angiotensin II to influence solute transport along the nephron have been well
documented (Barreto-Chaves and Mello-Aires, 1996; Cogan, 1990; Geibel et al., 1990;
Levine et al., 1996; Peti-Peterdi et al., 2002; Quan and Baum, 1998; Schuster et al., 1984;
Wang et al., 1996). We considered that the population of AT1 receptor in the proximal
tubule may directly impact BP regulation since the major portion of the glomerular filtrate is
reabsorbed here (Weinstein, 2008) and sodium transport by the proximal tubule may be a
major determinant of the pressure-natriuresis response (McDonough et al., 2003).
Furthermore, studies by Navar and Kobori have suggested that the proximal tubule is a key
site of an independently regulated intra-renal RAS serving as a source of angiotensinogen
and angiotensin II, which may influence nephron function (Kobori et al., 2007; Navar et al.,
2002). The capacity for angiotensinogen generated in the proximal tubule to affect blood
pressure was shown by Sigmund and associates in studies using transgenic mice expressing
human angiotensinogen and renin specifically in proximal tubule (Lavoie et al., 2004). On
the other hand, it has been suggested that the final adjustments of urinary sodium excretion
in the distal nephron are also important for body fluid volume homeostasis (Meneton et al.,
2004). In this regard, most of the human mutations with effects upon BP affect fluid
reabsorption in the distal portion of the nephron (Lifton et al., 2001).
We generated mice with specific deletion of AT1A receptors from epithelial cells in the
proximal tubule using the well-characterized PEPCK-Cre mouse line, which induces
excision of floxed alleles from epithelial cells in the proximal but not distal tubule (Higgins
et al., 2007; Rankin et al., 2006). We find that elimination of AT1A receptors from proximal
tubule causes a significant reduction of baseline BP by ≈10 mm Hg. Notwithstanding recent
reports of dominant actions of vascular signaling in BP control (Guilluy et al.; Heximer et
al., 2003; Michael et al., 2008; Wirth et al., 2008), the low BPs in the PTKOs occurred
despite intact constrictor responses to angiotensin II in the peripheral vasculature. This non-
redundant role for AT1 receptors in proximal tubule to determine BP level also suggests
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there is tonic stimulation of these receptors in the basal, euvolemic state consistent with
previous studies showing that acute administration of specific AT1 receptor blockers to rats
inhibits net proximal reabsorption (Thomson et al., 2006; Xie et al., 1990). Similarly, we
find that elimination of AT1A receptors from proximal tubule also reduces rates of fluid
reabsorption.
Agtr1a−/− mice with global deletion of AT1A receptors have exaggerated fluctuations in BP
with extremes of dietary sodium intake (sodium sensitivity) (Oliverio et al., 2000).
Enhanced sodium sensitivity is associated with absence of AT1A receptors from the kidney,
whereas elimination of receptors only from extra-renal tissues does not affect this response
(Crowley et al., 2005). Despite their lower basal BPs, the magnitude of BP changes during
high and low salt feeding was very similar in PTKOs and controls (Figure 1C). Thus,
deletion of AT1A receptors from the proximal tubule alone is not sufficient to generate a
phenotype of enhanced sodium sensitivity, indicating that AT1 receptors pools at other sites,
perhaps the distal nephron or renal vasculature, may control this response.
We find that elimination of AT1 receptors from proximal tubule provides significant
protection against angiotensin II-dependent hypertension, identifying this epithelial
compartment as a target of the RAS that is critical to the pathogenesis of hypertension.
Protection from hypertension is associated with enhanced natriuresis and altered sodium
balance, suggesting that modulation of sodium handling is critical for these actions. As
discussed above, activation of AT1 receptors stimulates fluid reabsorption in proximal
tubules (Schuster et al., 1984; Cogan, 1990) by triggering coordinate stimulation of the
luminal sodium-proton anti-porter (NHE3) along with the basolateral sodium-potassium
ATPase (Cogan, 1990; Geibel et al., 1990). Levels and localization of key sodium
transporters in the proximal tubule are modified during ACE inhibition, suggesting control
of their synthesis and cell trafficking by angiotensin II (Yang et al., 2007).
We examined the contributions of AT1 receptors in the proximal tubule in isolation to
regulate abundance of key sodium transporters in vivo in the intact animal. Under basal
conditions, there were no statistically significant differences in major transporter abundance
between the groups, although the levels of NHE3 tended to be lower in the PTKOs. In this
setting, the PTKO animals are in balance and their urinary excretion of sodium reflects
dietary intake. Therefore, it follows that their transporter profiles would not differ
dramatically from controls. Further, because of their reduced BPs and GFR, hemodynamic
factors such as changes in peritubular capillary pressures may also influence sodium
reabsorption in the PTKOs independent of absolute levels of epithelial transporters. By
contrast, the regulation of luminal transporters by AT1A receptors in proximal tubule is
clearly revealed when the steady state is abruptly modified during chronic infusion of
angiotensin II. With angiotensin II infusion, there was a significant reduction in NHE3
within the control group, compared to baseline. Such attenuation of NHE3 expression in
response to BP elevation has been described previously (McDonough et al., 2003), and may
be one mechanism facilitating natriuresis as pressure increases. The further and significant
reduction in NHE3 levels in the PTKOs compared to controls is consistent with a lower
threshold for pressure natriuresis in these mice, supported by the differences we observed in
net sodium balance (Figure 2C). We also found that NaPi2 expression during angiotensin II
infusion is regulated by AT1A receptors in the proximal tubule (Figure 3). Taken together,
these findings provide clear evidence for actions of AT1A receptors in the proximal tubule to
oppose adaptive reductions in key sodium transporters in the proximal tubule during
hypertension, with the net effect of impairing the pressure natriuresis response (Magyar and
McDonough, 2000). When this pathway is eliminated, the hypertensive response in is
attenuated (Figure 2A, B), highlighting the power of mechanisms controlling renal solute
reabsorption in the proximal tubule to determine BP levels.
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In summary, our studies show that the epithelium of the proximal tubule is a critical location
for integrating signals to set the level of intra-arterial pressure. This is accomplished though
modulation of tubular fluid reabsorption and regulated expression of sodium transporter
proteins. The RAS provides tonic control of this pathway supporting BP independent of its
vascular actions. Furthermore, it is likely that other neuro-hormonal systems exploit these
proximal tubular mechanisms for physiological control (DiBona, 2005; Zeng et al., 2009;
Zhang et al., 2009). Our data suggest that effective inhibition of sodium reabsorption in the
renal proximal tubule could be a useful therapeutic strategy in hypertension, supplementing
the range of diuretic agents currently used to target sodium reabsorption in distal nephron
segments. Our studies further suggest that blockade of this pathway is likely a key




Inbred 129/SvEv mice with a conditional Agtr1a allele were generated as described in
Supplemental Material. The Pepck-Cre transgene was back-crossed more than 10
generations onto the 129/SvEv background. Mice were bred and maintained in the animal
facility at the Durham VA Medical Center according to NIH guidelines.
BP measurements in conscious mice
BPs were measured in conscious mice using radiotelemetry, as described previously
(Crowley et al., 2005).
Sodium Balance Studies
Measurements of sodium balance were carried out as previously described (Crowley et al.,
2006) with individual metabolic cages and a gel diet containing nutrients, water and 0.1% w/
w sodium (Nutra-gel; Bio-Serv, Frenchtown, NJ).
Micropuncture Studies
Mice were anesthetized and prepared for micropuncture studies as described previously
(Hashimoto et al., 2005). To determine nephron filtration and absorption rates, 125I
iothalamate (Glofil, Questcor Pharmaceuticals, Hayward, CA) was infused at ~40 μCi/hr. A
blood sample was collected after 20–25 min of equilibration, and free flow micropuncture
was performed.
Immunoblot Analysis
Levels of renal transporter proteins were determined as described previously (Yang et al.,
2007). Kidneys were de-capsulated and individually homogenized, centrifuged, and
supernatant “homogenate” retained. A constant amount of homogenate protein from each
animal was denatured, resolved on 7.5% SDS-polyacrylamide gels, and transferred to a
single polyvinylidene difluoride membrane (Millipore Immobilon-P). After blocking, blots
were incubated with specific antibodies (listed in Supplemental Material). Sample amounts
were determined to be in the linear range of detection, and signals were quantitated with the
Odyssey Infrared Imaging System (LI-COR, Lincoln, NB). Data for each protein were
normalized to the mean of expression in the control non-infused group defined as 1.0.
Statistical analysis
The values for each parameter within a group are expressed as the mean ± the standard error
of the mean (SEM). For comparisons between groups, statistical significance was assessed
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using ANOVA followed by unpaired t test adjusted for multiple comparisons (normally
distributed data), and the Mann Whitney U test was employed for non-parametric data. For
comparisons within groups, normally distributed variables were analyzed by a paired t test,
whereas non-parametric analysis was with the Wilcoxon signed rank test. Normality was
determined using the Shapiro-Wilk W test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Baseline studies in PTKO mice
(A) 12-hour mean systolic BPs during the day (d) and at night (n) on a control diet. Systolic
BPs were significantly lower in PTKO mice compared to controls (*p=0.03). (B) BPs
increased significantly (†p<0.01) and to a similar extent in PTKO and controls during high
salt (6% NaCl) feeding and returned to baseline values on low salt (<0.02% NaCl). BPs
were significantly lower in the PTKOs throughout the experiment (*p<0.044). (C) The
maximal increases in mean arterial pressure (MAP) compared to baseline in response to
bolus infusions of angiotensin II (1 and 10 μg/kg) or epinephrine (10 μg/kg) were identical
between PTKOs and controls. (D) Rates of fluid reabsorption by the renal PT measured in
vivo using standard free flow micropuncture were significantly reduced in the PTKO mice
compared to controls as an absolute rate (p=0.00011) or (F) when adjusted for single-
nephron glomerular filtration rate (p=0.0007). Error bars represent SEM.
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Figure 2. AT1A receptors in the proximal tubule promote hypertension
(A) With infusion of ang II (1000ng/kg/min), BPs increased significantly in both control and
PTKO mice but the hypertensive response to angiotensin II was significantly attenuated in
the PTKOs (**p<0.001). (B) The mean increase in BP during the angiotensin II infusion
was significantly less in the PTKOs (23±3 mm Hg) compared to controls (black bars; 38±5
mm Hg, *p=0.0005). (C) Cumulative sodium balance was significantly lower in the PTKOs
(n=8) than controls (n=7, *p=0.046) during the first 3 days of ang II infusion. Error bars
represent SEM.
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Figure 3. Abundance of Sodium Transporters in Control and PTKO mice
Protein levels of key transporters in kidneys of PTKO and control mice including NHE3 (A,
B), NaPi2 (C,D), and NKCC2 (E, F) were measured by western blot. Numbers below the
blots indicate the mean ± S.E.M of the sample density normalized to the control baseline set
(arbitrarily defined as 1.0). The densitometry data are in bar graphs (B, D, and F) where *
indicates p<0.05.
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Table 1
Physiological Data
Control (n=8) PT KO (n=7) P Value
Body weight (g) 32.4 ± 1.73 30 ± 1.54 ns
Kidney weight (mg) 435.4 ± 19.8 410 ± 22.1 ns
Glomerular Filtration Rate, GFR (μL/min) 620±49 439±58 0.025
U osm (mOsm/kgH2O) 2441.4 ± 103 2165 ± 102 0.15
UV (μl/min) 1.5 ± 0.08 2.1 ± 0.17 0.005
Proximal Tubule Micropuncture
TF/P iothal 1.85 ± 0.05 1.6 ± 0.03 0.0002
Absorption (nl/min) 7.5 ± 0.58 4.76 ± 0.32 0.000
Fractional Abs (%) 44.45 ± 1.57 36.5 ± 1.53 0.0005
Data represent values ± SEM.
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